2025 annual financial data
Aytu BioPharma 2025 Net income
Direct answer
Net income was -13,562,000 USD.
Operating income was -7,827,000 USD and net income was -13,562,000 USD.
Operating cash flow was -1,937,000 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 66,382,000 USD
- Operating income
- -7,827,000 USD
- Net income
- -13,562,000 USD
- Operating cash flow
- -1,937,000 USD